Review
High-dose Mydocalm therapy in certain myogenous headaches
- PMID: 2686081
Item in Clipboard
Review
High-dose Mydocalm therapy in certain myogenous headaches
Ther Hung.
1989.
Abstract
Oral Mydocalm intermittent therapy was used in 113 patients suffering from myogenous cephalalgia. Daily 3 +/- 150 mg tolperisonum doses relieved, within 3-7 days, spasm, hypertonicity, rigidity of occipital, cervical, and shoulder muscles, and resulted in functional improvement and successfully controlled myogenous cephalalgias.
Similar articles
-
Observations with high-dose Mydocalm therapy.Ther Hung. 1993;41(2):51-4. Ther Hung. 1993. PMID: 8278938 Clinical Trial.
-
Adjuvant effect of oral Mydocalm treatment with massive doses in locomotor disease patients.Ther Hung. 1987;35(3):152-5. Ther Hung. 1987. PMID: 3438877 No abstract available.
-
A phase IV observational multi-centre, open-label study on efficacy and safety of tolperisone 150 mg in patients with painful muscle spasm associated with degenerative or inflammatory diseases of the musculoskeletal system.J Assoc Physicians India. 2011 Jan;59:33-7. J Assoc Physicians India. 2011. PMID: 21751662 Clinical Trial.
-
Observations with intensive Mydocalm treatment in neurological cases.Ther Hung. 1987;35(2):66-70. Ther Hung. 1987. PMID: 3326207 Review. No abstract available.
-
Risk factors for and sequelae of headaches in schoolchildren with clinical implications from a psychosocial perspective.J Pediatr Nurs. 2001 Dec;16(6):392-401. doi: 10.1053/jpdn.2001.27879. J Pediatr Nurs. 2001. PMID: 11740786 Review.
Cited by
-
Tolperisone: a typical representative of a class of centrally acting muscle relaxants with less sedative side effects.CNS Neurosci Ther. 2008 Summer;14(2):107-19. doi: 10.1111/j.1527-3458.2008.00044.x. CNS Neurosci Ther. 2008. PMID: 18482024 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical